Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows revision v3.6.3 instead of v3.6.2, indicating a new site revision tag. This is an administrative version update and does not modify the study data or available actions.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2. This reflects a minor update to the page's underlying versioning, likely affecting the template or UI elements without altering the study content.SummaryDifference0.1%

- Check25 days agoChange DetectedNo textual changes are captured for this page in the provided dataset. The screenshots suggest a comparison, but no text changes are recorded in the change feed.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study page now indicates that recruitment is closed to new participants, and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a footer revision update (v3.6.0 replacing v3.5.5).SummaryDifference0.4%

- Check39 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This appears to be a small maintenance update rather than a alteration to the study details or user-facing information.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was deleted, indicating a page version update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.